Anna R. Franklin

1.5k total citations
41 papers, 1000 citations indexed

About

Anna R. Franklin is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Anna R. Franklin has authored 41 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 15 papers in Pediatrics, Perinatology and Child Health and 11 papers in Oncology. Recurrent topics in Anna R. Franklin's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (15 papers) and Lymphoma Diagnosis and Treatment (10 papers). Anna R. Franklin is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (15 papers) and Lymphoma Diagnosis and Treatment (10 papers). Anna R. Franklin collaborates with scholars based in United States, Italy and Netherlands. Anna R. Franklin's co-authors include Brandon Hayes‐Lattin, Lori A. Zoellner, Elizabeth H. Marks, Karen Albritton, Maurizio Mascarin, Winette van der Graaf, Andrea Ferrari, David M. Thomas, Michelle A. Fanale and Eric L. Sievers and has published in prestigious journals such as Journal of Clinical Oncology, Psychological Bulletin and Blood.

In The Last Decade

Anna R. Franklin

40 papers receiving 985 citations

Peers

Anna R. Franklin
Hiroko Inada Japan
ZoAnn E. Dreyer United States
Peter Downie Australia
Ian Toogood Australia
Keiko Asami Japan
Lisa Orme Australia
Carol S. Bruggers United States
Kimberly Whelan United States
Carol Greenwald United States
Mary J. Waskerwitz United States
Hiroko Inada Japan
Anna R. Franklin
Citations per year, relative to Anna R. Franklin Anna R. Franklin (= 1×) peers Hiroko Inada

Countries citing papers authored by Anna R. Franklin

Since Specialization
Citations

This map shows the geographic impact of Anna R. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna R. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna R. Franklin more than expected).

Fields of papers citing papers by Anna R. Franklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna R. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna R. Franklin. The network helps show where Anna R. Franklin may publish in the future.

Co-authorship network of co-authors of Anna R. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna R. Franklin. A scholar is included among the top collaborators of Anna R. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna R. Franklin. Anna R. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burns, Karen, Christine Phillips, Robert E. Brannigan, et al.. (2023). Male pediatric, adolescent, and young adult reproductive survivorship. Pediatric Blood & Cancer. 70(S5). e28823–e28823. 2 indexed citations
2.
Vigers, Tim, et al.. (2022). Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes Technology & Therapeutics. 25(2). 116–121. 1 indexed citations
3.
Ragoonanan, Dristhi, Anna R. Franklin, Chandra Srinivasan, et al.. (2021). Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature. Cancers. 13(22). 5814–5814. 3 indexed citations
4.
Franklin, Anna R., Mara Albonei Dudeque Pianovski, Franca Fagioli, et al.. (2021). AN OPEN‐LABEL, PHASE 1/2 STUDY OF FRONTLINE BRENTUXIMAB VEDOTIN + ADRIAMYCIN, VINBLASTINE, AND DACARBAZINE IN PAEDIATRIC PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA. Hematological Oncology. 39(S2). 2 indexed citations
5.
Franklin, Anna R., Danielle C. Mathersul, Adrian Raine, & Ayelet Meron Ruscio. (2020). Restlessness in Generalized Anxiety Disorder: Using Actigraphy to Measure Physiological Reactions to Threat. Behavior Therapy. 52(3). 734–744. 7 indexed citations
6.
Franklin, Anna R., et al.. (2020). Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology. 43(6). e897–e899. 6 indexed citations
7.
Zoellner, Lori A., Belinda Graham, Elizabeth Marks, et al.. (2018). Islamic Trauma Healing: Initial Feasibility and Pilot Data. Societies. 8(3). 47–47. 25 indexed citations
8.
Marks, Elizabeth H., Anna R. Franklin, & Lori A. Zoellner. (2018). Can’t get it out of my mind: A systematic review of predictors of intrusive memories of distressing events.. Psychological Bulletin. 144(6). 584–640. 74 indexed citations
9.
10.
DiNardo, Courtney D., Sarah A. Bannon, Mark J. Routbort, et al.. (2016). Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clinical Lymphoma Myeloma & Leukemia. 16(7). 417–428.e2. 66 indexed citations
11.
Tewari, Priti, et al.. (2014). Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults. Acta Haematologica. 132(3-4). 313–325. 11 indexed citations
12.
Benton, Christopher B., Deborah A. Thomas, Hui Yang, et al.. (2014). Safety and clinical activity of 5‐aza‐2′‐deoxycytidine (decitabine) with or without Hyper‐CVAD in relapsed/refractory acute lymphocytic leukaemia. British Journal of Haematology. 167(3). 356–365. 33 indexed citations
13.
Fanale, Michelle A., Andres Forero‐Torres, Joseph D. Rosenblatt, et al.. (2011). A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies. Clinical Cancer Research. 18(1). 248–255. 160 indexed citations
14.
Fang, Wendy, et al.. (2011). Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin. Leukemia Research. 35(6). 814–820. 44 indexed citations
15.
Rytting, Michael, Deborah A. Thomas, Elias Jabbour, et al.. (2011). Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy. Blood. 118(21). 1527–1527. 1 indexed citations
16.
17.
Zage, Peter E., Chen Zhao, Wendy Fang, et al.. (2010). The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma. Investigational New Drugs. 30(1). 191–199. 37 indexed citations
18.
Rytting, Michael, Hagop M. Kantarjian, Deborah A. Thomas, et al.. (2010). Adolescent and Young Adult Patients Treated with Modified Augmented Berlin-Frankfurt-Muenster Therapy. Blood. 116(21). 3250–3250. 3 indexed citations
19.
Fanale, Michelle A., Nancy L. Bartlett, Andres Forero‐Torres, et al.. (2009). The Antibody-Drug Conjugate Brentuximab Vedotin (SGN-35) Induced Multiple Objective Responses in Patients with Relapsed or Refractory CD30-Positive Lymphomas in a Phase 1 Weekly Dosing Study.. Blood. 114(22). 2731–2731. 24 indexed citations
20.
Chinen, Javier, et al.. (2007). Long-term follow-up of patients with primary immunodeficiencies. Journal of Allergy and Clinical Immunology. 120(4). 795–797. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Inada Breakdown of academic impact, for papers by ZoAnn E. Dreyer Breakdown of academic impact, for papers by Peter Downie Breakdown of academic impact, for papers by Ian Toogood Breakdown of academic impact, for papers by Keiko Asami Breakdown of academic impact, for papers by Lisa Orme Breakdown of academic impact, for papers by Carol S. Bruggers Breakdown of academic impact, for papers by Kimberly Whelan Breakdown of academic impact, for papers by Carol Greenwald Breakdown of academic impact, for papers by Mary J. Waskerwitz
Rankless by CCL
2026